Apical hypertrophic cardiomyopathy (ApHCM) had less myocardial fibrosis and milder diastolic dysfunction, leading to a more favorable disease course than non-apical HCM.
Does apical hypertrophic cardiomyopathy have a more benign clinical course and different imaging characteristics compared to non-apical hypertrophic cardiomyopathy?
Apical hypertrophic cardiomyopathy is associated with less myocardial fibrosis, milder diastolic dysfunction, and a more benign clinical course compared to non-apical variants.
Absolute Event Rate: 0% vs 0%
ApHCM showed a relatively small burden of myocardial fibrosis and less severe diastolic dysfunction and subsequently more favourable clinical manifestations in comparison with other HCMs. This may be one explanation of why most patients with ApHCM show a benign course of disease compared with non-ApHCM.
Kim et al. (Tue,) reported a other. Apical hypertrophic cardiomyopathy (ApHCM) had less myocardial fibrosis and milder diastolic dysfunction, leading to a more favorable disease course than non-apical HCM.